arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Protalix BioTherapeutics, Inc.

PLX Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$2.38
▼ -0.2% Today
as of Jul 22, 16:53 ET
Last 30 days +13.40% Jun 12 → Jul 22
$1.99 $2.11 $2.23 $2.35 $2.47 Jun 12 Jun 22 Jun 29 Jul 08 Jul 15 Jul 22
Open
$1.99
High
$2.02
Low
$1.98
Volume
$545,868
Avg Vol
$900,731
Mkt Cap
$194M
P/E (TTM)
7.96
Beta
52w High
$3.19
52w Low
$1.32
Div Yield
Shares Out

Overview

52-week range
$1.32
$3.19
57% of range
Avg surprise (last 3)
+679.2%
Avg reaction (last 2)
-19.7%
50% positive
Latest IV / EM
37%
EM ±8.4% · $3 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.06$0.01$0.08$0.15$0.22 Actual $0.21Actual $-0.04Actual $-0.06Actual $-0.03Actual $0.03Actual $-0.05Est $0.08Est $0.03Actual $0.03Actual $0.22Est $-0.01 JunSepMarJunSepMar/2025Jun/2025SepMar/2026
Revenue vs Net Income Revenue Net income
$-4M$6M$16M$26M$35M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $0.22 $-0.01 +2,300% +540.0% +1.0% earnings
Tue Sep 30, 2025Sep 2025 $0.03 financials
Thu Aug 14, 2025Jun/2025 $0.03 -100.0% earnings
Fri May 9, 2025Mar/2025 $-0.05 $0.08 -162.5% -40.5% earnings
Mon Sep 30, 2024Sep 2024 $0.03 financials
Sun Jun 30, 2024Jun 2024 $-0.03 financials
Sun Mar 31, 2024Mar 2024 $-0.06 financials
Sat Sep 30, 2023Sep 2023 $-0.04 financials
Fri Jun 30, 2023Jun 2023 $0.21 financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Thu Aug 13, 2026Jun/2026OTHER -$0.01

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$34M$18M$16M$10M$18M$13M
Cost of revenue$4M$8M$6M$8M$8M$9M
Gross profit
Operating income$21M$2M$1M$-4M$4M$-2M
Net income$18M$2M$164,000$-4M$3M$-2M
EPS (diluted)$0.22$0.03$-0.05$0.03$-0.03

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$41M$15M$14M$18M$19M$20M$27M$23M
Inventory$30M$26M$21M$21M$20M$21M$17M$21M
Total current assets$86M$67M$67M$65M$61M$60M$48M$77M
Total assets$102M$82M$82M$78M$74M$73M$62M$92M
Long-term debt
Total liabilities$35M$34M$29M$29M$29M$30M$29M$63M
Total equity$67M$48M$53M$50M$45M$43M$32M$29M

Implied volatility — last 90 days

33%110%188%266%343% Jun 07 — IV 200% · EM ±27.6%Jun 08 — IV 215% · EM ±28.3%Jun 09 — IV 242% · EM ±30.3%Jun 10 — IV 344% · EM ±40.6%Jun 11 — IV 132% · EM ±14.6%Jun 12 — IV 257% · EM ±26.3%Jun 19 — IV 194% · EM ±42.8%Jun 22 — IV 33% · EM ±6.9%Jun 23 — IV 46% · EM ±9.4%Jun 24 — IV 111% · EM ±22.3%Jun 25 — IV 34% · EM ±6.8%Jun 26 — IV 34% · EM ±6.5%Jun 29 — IV 36% · EM ±6.3%Jun 30 — IV 37% · EM ±6.4%Jul 01 — IV 52% · EM ±8.7%Jul 02 — IV 93% · EM ±15.1%Jul 03 — IV 97% · EM ±15.1%Jul 06 — IV 47% · EM ±6.5%Jul 07 — IV 48% · EM ±6.4%Jul 08 — IV 50% · EM ±6.3%Jul 09 — IV 54% · EM ±6.3%Jul 10 — IV 56% · EM ±6.1%Jul 13 — IV 125% · EM ±10.5%Jul 20 — IV 61% · EM ±14.5%Jul 21 — IV 55% · EM ±12.7%Jul 22 — IV 37% · EM ±8.4%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.